We have a high impact and scalable business model to bring evidence-based PTSD treatment to anyone in need, especially those in humanitarian emergencies.
As our business matures, we will become a self-funded organization, raising money by treating people with PTSD through a market cross-subsidy approach: the more people pay a fair price for treatment in stable economies, the more financial resources we will have to invest in clinical efficacy research and offer free evidence-based care to those who can't afford it.
We are committed to conducting rigorous scientific research, with a strong focus on neuroscience, culture and technology, to ensure treatment efficacy and to evolve innovative models of dissemination.
Proposal in Development
Trauma Care via NF-Integrated non-Exposure Virtual Reality (Child and Adult versions).
eResilience App Clinical Trial (2015-2018)
Examining Efficacy of the eResilience App in Reducing Symptoms of Trauma via Brain Changes and Cognitive Performance. The study, entering its final year, is being conducted by Miss Pinto, Sync’s founder, at the University of Sydney in Australia.
eResilience Pilot Field Implementation (2017-2018)
The Sankofa Project was launched in June of 2017 at an Ebola-impacted community in Liberia, West Africa, to examine clinical efficacy of the intervention curriculum (digitised as the eResilience App) developed and utilised with seven thousand war survivors. Our teams are conducting a throughout follow-up of 100 beneficiaries at 3, 6, and 12 months. A final remaining 47 participants are pending the 12-month follow-up in December of 2018 for conclusion of the project. All interviews utilised (PCL-5, WHODAS 2.0, PHQ-9, and GPS) are being conducted by highly trained staff on a one-to-one basis with each participant.